Prognostic relevance of myelodysplasia in de novo and secondary AML.

被引：0
|
作者：
Schaekel, U [1 ]
Brocard, B [1 ]
Kroschinsky, F [1 ]
Schaich, M [1 ]
Soucek, S [1 ]
Neubauer, A [1 ]
Ehninger, G [1 ]
机构：
[1] Tech Univ Dresden, Univ Klinikum CG Carus, Med Klin & Poliklin 1, Study Ctr AML96,Study Grp, D-8027 Dresden, Germany
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
453
引用
收藏
页码：106A / 106A
页数：1
相关论文
共 50 条
  • [41] Combination HDACi and mTOR inhibitor therapy in poor-risk de novo and refractory elderly patients with AML.
    Sandilya, Vijay Krishna
    Ghai, Vikas
    Sharma, Kamal
    Abbi, Kamal Kant Singh
    Epner, Elliot E.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [42] Expression and prognostic significance of survivin in de novo acute myeloid leukemia (AML).
    Adida, C
    Recher, C
    Raffoux, E
    Daniel, MT
    Taksin, AL
    Rousselot, P
    Sigaux, F
    Degos, L
    Altieri, DC
    Dombret, H
    BLOOD, 2000, 96 (11) : 698A - 698A
  • [43] Survivin and VEGF mRNA expression in elderly patients with de novo or secondary AML
    Tsiga, A.
    Avgitidou, A.
    Ioannidou-Papayannaki, E.
    Vlachaki, E.
    Klonizakis, E.
    Kalogeridis, A.
    Haralambidou-Vranitsa, S.
    Klonizakis, I.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 417 - 417
  • [44] LATE APPEARANCE OF THE PHILADELPHIA-CHROMOSOME WITH MONOSOMY 7 IN A PATIENT WITH DE-NOVO AML WITH TRILINEAGE MYELODYSPLASIA
    MATSUE, K
    MIYAMOTO, T
    ITO, M
    TSUKUDA, K
    AMERICAN JOURNAL OF HEMATOLOGY, 1995, 49 (04) : 341 - 346
  • [45] THERAPY-RELATED ACUTE MYELOID LEUKEMIA (T-AML) VERSUS AML WITH MYELODYSPLASIA-RELATED CHANGES AND DE NOVO AML: CLINICOBIOLOGICAL DIFFERENCES AND OUTCOME
    Lalayanni, C.
    Antoniou, A.
    Baliakas, P.
    Iskas, M.
    Georgiadou, E.
    Marvaki, A.
    Syrigou, A.
    Athanasiadou, A.
    Anagnostopoulos, A.
    HAEMATOLOGICA, 2012, 97 : 503 - 503
  • [46] CLINICAL OUTCOME OF HYPOCELLULAR AML AND AML WITH MYELODYSPLASIA-RELATED CHANGE (MRC) COMPARED TO DE NOVO ADULT AML WITH NORMAL CELLULARITY AFTER HEMATOPOIETIC CELL TRANSPLANTATION
    Kwak, D. -H.
    Yoon, J. -H.
    Kim, H. -J.
    Park, S. -S.
    Lee, S. -E.
    Cho, B. -S.
    Eom, K. -S.
    Kim, Y. -J.
    Lee, S.
    Lee, J. -W.
    Min, W. -S.
    HAEMATOLOGICA, 2017, 102 : 217 - 217
  • [47] Atypical antigen expression on myeloblasts as a favorable prognostic factor in de novo adult AML
    Balana-Nowak, A.
    Zdzilowska, E.
    Skotnicki, A. B.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2007, 72B (02) : 147 - 148
  • [48] Prognostic factors predicting survival in de novo AML patients requiring intensive care
    Schellongowski, Peter
    Staudinger, Thomas
    Laczika, Klaus
    Locker, Gottfried
    Bojic, Andja
    Jaeger, Ulrich
    Valent, Peter
    Sperr, Wolfgang R.
    BLOOD, 2007, 110 (11) : 841A - 841A
  • [49] Clinical relevance of bcl-2 expression in de novo acute myeloid leukemia (AML).
    Del Poeta, G
    Venditti, A
    Maurillo, L
    Buccisano, F
    Tamburini, A
    Cox, MC
    Epiceno, AM
    Del Moro, B
    Battaglia, A
    Del Principe, MID
    Bruno, A
    Masi, M
    Amadori, S
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (07) : 72 - 72
  • [50] De novo AML with trilineage myelodysplasia and a novel t(11;12)(p15;q13)
    Wong, KF
    Kwong, YL
    So, CC
    CANCER GENETICS AND CYTOGENETICS, 1998, 100 (01) : 49 - 51
12345